Literature DB >> 3543499

Structure and bioactivity of the amino-terminal fragment of pro-opiomelanocortin.

M A Seger, H P Bennett.   

Abstract

The primary sequence of the amino-terminal or 16 K fragment (16 K) of pro-opiomelanocortin (POMC) is highly conserved throughout the mammals. This suggests an important biological role for this peptide. We have performed studies to determine the structure, biosynthetic origin and bioactivity of this pituitary peptide. A comprehensive study of all the biosynthetic derivatives of POMC in the neurointermediate lobe of the rat and mouse pituitary was undertaken. Inspection of the amino acid composition of these peptides indicated that cleavage at all available dibasic processing sites within POMC is essentially complete except for Arg49-Lys50 within the 1-74 16 K fragment (16 K1-74). Only about 50% of 16 K1-74 was found to be processed to give rise to the extreme amino-terminal 1 to 49 sequence (16 K1-49) and the carboxyl-terminal 50 to 74 sequence (Lys1 gamma 3 melanotropin). Sufficient 16 K1-77 and 16 K1-49 was purified from bovine posterior pituitaries in order to determine if there are any structural features controlling the limited degree of processing of 16 K within the intermediate lobe. Both bovine 16 K1-77 and 16 K1-49 were found to have cystine bridges linking cystine residues 2 and 24 and linking cystine residues 8 and 20. While 16 K1-77 was found to be O-glycosylated at threonine45 and N-glycosylated as asparagine65, 16 K1-49 was found to have no carbohydrate content. Thus the presence of O-glycosylation at threonine45 apparently inhibits cleavage at -Arg49-Lys50-. Lys1 gamma 3 MSH 16 K1-74 and 16 K1-49 purified from rat neurointermediate pituitaries were tested for their ability to potentiate the action of corticotropin (ACTH) in an isolated rat adrenal cell bioassay. None of the 16 K-related peptides showed any intrinsic steroidogenic activity. Experiments were performed in which dispersed adrenal cells were incubated with serial dilutions of ACTH. Constant amounts of test peptides were added in concentrations ranging from 10 pM to 5 nM. Lys1 gamma 3 MSH potentiated the steroidogenic activity of ACTH by up to 2-fold with an ED50 of approx 0.5 nM. 16 K1-49 showed no ability to potentiate the action of ACTH. In contrast the most highly glycosylated form of 16 K1-74 potentiated the action of ACTH by up to 6-fold.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3543499     DOI: 10.1016/0022-4731(86)90298-0

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  12 in total

Review 1.  Intracellular trafficking and processing of pro-opiomelanocortin.

Authors:  Y P Loh; K I Andreasson; N P Birch
Journal:  Cell Biophys       Date:  1991 Oct-Dec

Review 2.  The enzymology of proinsulin conversion.

Authors:  J C Hutton; C J Rhodes
Journal:  Cell Biophys       Date:  1991 Oct-Dec

3.  Bilateral adrenal enucleation-induced changes in adenohypophyseal pro-opiomelanocortin (POMC)-related peptides synthesis and secretion: a comparative study with adrenalectomized rats.

Authors:  M J Perone; A N Chisari; C L Gómez Dumm; E Spinedi; F E Estivariz
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

Review 4.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids.

Authors:  Katrine T-B G Schjoldager; Malene B Vester-Christensen; Eric Paul Bennett; Steven B Levery; Tilo Schwientek; Wu Yin; Ola Blixt; Henrik Clausen
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

6.  Pro-gamma-MSH levels in various disorders of pituitary-adrenal axis.

Authors:  M Boscaro; P Giacomazzi; N Sonino; F Fallo; F Girard; X Bertagna; F Mantero
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

7.  Isolation and characterization of two peptides with prolactin release-inhibiting activity from porcine hypothalami.

Authors:  A V Schally; J G Guoth; T W Redding; K Groot; H Rodriguez; E Szonyi; J Stults; K Nikolics
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 8.  60 YEARS OF POMC: Biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides.

Authors:  Niamh X Cawley; Zhaojin Li; Y Peng Loh
Journal:  J Mol Endocrinol       Date:  2016-02-15       Impact factor: 5.098

9.  Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production.

Authors:  Anthony P Coll; Martin Fassnacht; Steffen Klammer; Stephanie Hahner; Dominik M Schulte; Sarah Piper; Y C Loraine Tung; Benjamin G Challis; Yacob Weinstein; Bruno Allolio; Stephen O'Rahilly; Felix Beuschlein
Journal:  J Endocrinol       Date:  2006-08       Impact factor: 4.286

10.  Incomplete posttranslational prohormone modifications in hyperactive neuroendocrine cells.

Authors:  Jeroen R P M Strating; Gerard J M Martens
Journal:  BMC Cell Biol       Date:  2009-05-07       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.